Gestational hypertensive disease and small for gestational age infants in twin pregnancy: A systematic review and

Mingbo Wang1, Xin Wang1, Zhifang Chen2

  • 1Medical School of Nantong University, Nantong, China.

Insights

Gestational hypertension diseases (GHD) increase the risk of small for gestational age (SGA) in dichorionic twin pregnancies. The diagnostic reference for SGA significantly impacts the observed association between GHD and SGA outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Maternal-Fetal Medicine

Background:

  • Gestational hypertension diseases (GHD) and small for gestational age (SGA) are significant complications in twin pregnancies.
  • Understanding the relationship between GHD and SGA is crucial for optimizing perinatal outcomes in multiple gestations.

Approach:

  • A systematic review and meta-analysis were conducted following PRISMA guidelines.
  • Studies were systematically searched across major databases (PubMed, Web of Science, Cochrane Library, Embase) until January 2022.
  • Subgroup analyses were performed based on chorionicity and SGA diagnostic criteria, utilizing random-effect or fixed-effect models as appropriate.

Key Points:

  • The overall analysis indicated an increased risk of SGA in twin pregnancies complicated by GHD (OR = 1.57).
  • The association between GHD and SGA was significant when using twin birth weight references for SGA diagnosis (OR = 2.14) but not when using singleton birth weight references (OR = 1.17).
  • SGA was significantly associated with GHD in dichorionic (DC) twin pregnancies (OR = 1.68) but not in monochorionic (MC) twin pregnancies (OR = 1.68).

Conclusions:

  • Gestational hypertension diseases in dichorionic twin pregnancies are linked to a higher risk of developing small for gestational age infants.
  • The choice of diagnostic reference for SGA significantly influences the observed association with GHD in twin pregnancies.
  • Further research is warranted to confirm these findings and elucidate the underlying mechanisms.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
33